2 of 53

Bayer Group Consolidated Balance Sheets

	Note	Dec. 31, 2007	Dec. 31, 2008
		€ million	€ million
Noncurrent assets
Goodwill	[17]	8,215	8,647
Other intangible assets	[17]	14,555	13,951
Property, plant and equipment	[18]	8,819	9,492
Investments in associates	[19]	484	450
Other financial assets	[20]	1,127	1,197
Other receivables	[23]	667	458
Deferred taxes	[14]	845	1,156
		34,712	35,351
Current assets
Inventories	[21]	6,217	6,681
Trade accounts receivable	[22]	5,830	5,953
Other financial assets	[20]	335	634
Other receivables	[23]	1,461	1,284
Claims for income tax refunds		208	506
Cash and cash equivalents	[36]	2,531	2,094
Assets held for sale and discontinued operations	[6.3]	84	8
		16,666	17,160

Total assets		51,378	52,511

Stockholders‘ equity	[24]
Capital stock of Bayer AG		1,957	1,957
Capital reserves of Bayer AG		4,028	4,028
Other reserves		10,749	10,278
		16,734	16,263
Equity attributable to non-controlling interest		87	77
		16,821	16,340

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	[25]	5,501	6,347
Other provisions	[26]	1,166	1,351
Financial liabilities	[27]	13,081	10,614
Other liabilities	[29]	331	432
Deferred taxes	[14]	3,866	3,592
		23,945	22,336
Current liabilities
Other provisions	[26]	3,754	3,163
Financial liabilities	[27]	1,336	6,256
Trade accounts payable	[28]	2,466	2,377
Income tax liabilities	[26.1]	56	65
Other liabilities	[29]	2,824	1,961
Liabilities directly related to assets held for sale and discontinued operations	[6.3]	176	13
		10,612	13,835

Total stockholders‘ equity and liabilities		51,378	52,511
2007 figures restated